My Photo

Moselio Schaechter

  • The purpose of this blog is to share my appreciation for the width and depth of the microbial activities on this planet. I will emphasize the unusual and the unexpected phenomena for which I have a special fascination... (more)

    For the memoirs of my first 21 years of life, click here.

Associate Bloggers



  • (Click photo for more information.)

Bloggers Emeriti


  • (Click photo for more information.)

Meetings & Sponsors

Awards

« The Façade of E. coli K-12 | Main | Phage Lambda’s Polar Expedition »

October 20, 2011

Comments

Lynda McKee

Very interesting and proof again of the power that Quorum Sensing in bacteria holds, not only in allowing the structure of the biofilm to decrease the effectiveness of antibiotic therapy but also to inhibit the natural bacteria killer -Phage!!
I wonder if future treatments might combine perhaps Phage Therapy and QS drenching analogs??

Merry replies: That sounds like a good strategy, Lynda. If we could inhibit biofilm production using analogs to disrupt the bacterial quorum sensing, then the phage might be able to help us in controlling the resilient CF pathogens. Phage therapy could give us more phage on our side, phages specific for the CF pathogens.

Alice M

Seems Phage therapy could make its long deserved comeback hopefully in a few years.

Merry replies: Phage therapy for CF is definitely an active area of research now. One tact is to use phages with enhanced capabilities to digest the polysaccharides in the biofilms, thus giving them easier access to the lurking bacteria.

Howard Cash

It's possible all the cells of Pseudomonas aeruginosa (Pa) in these occluded lobes are descendants of one strain selected for mucoidy by lysogenic conversion. This single clone would belong to a single phage immunity group which would abort continued lysogenic cycles and hence no free phage. I suspect that these bacteria contain just one temperate phage that has the ability to select for or convert to mucoidy other isolates of Pa. Please see: R.V. Miller and V.J. Renta Rubero. Mucoid Conversion by Phages of Pseudomnas aeruginosa Strains from Patients with Cystic Fibrosis. J. Clin. Microbiol. 19:717-719 (1984). Phage therapy would have to consider phage less likely to convert cells to mucoidy and from different immunity groups.

Merry replies: Good point! The same authors had published a survey of the microbial communities in these lobes and I had checked there earlier for any hints of prophages. There are a growing number of environments known now where temperate phages predominate. But their microbial sruvey was based on 16S amplicons only, with no other genomic sequencing. You tied all this together into a possible scenario. I do hope some researchers are looking in those directions.

Verify your Comment

Previewing your Comment

This is only a preview. Your comment has not yet been posted.

Working...
Your comment could not be posted. Error type:
Your comment has been saved. Comments are moderated and will not appear until approved by the author. Post another comment

The letters and numbers you entered did not match the image. Please try again.

As a final step before posting your comment, enter the letters and numbers you see in the image below. This prevents automated programs from posting comments.

Having trouble reading this image? View an alternate.

Working...

Post a comment

Comments are moderated, and will not appear until the author has approved them.

Teachers' Corner

Podcast

How to Interact with This Blog

  • We welcome readers to answer queries and comment on our musings. To leave a comment or view others, remarks, click the "Comments" link in red following each blog post. We also occasionally publish guest blog posts from microbiologists, students, and others with a relevant story to share. If you are interested in authoring an article, please email us at elios179 at gmail dot com.

Subscribe via email

  • Enter your email address:

Translate




Search




MicrobeWorld News

Membership